NASDAQ · Financial Statements
AlloVir, Inc. (ALVR) Financial Statements
$9.81
NASDAQ: ALVR
Market Cap $49.48M
Overview Financials Dividend
AlloVir, Inc. most recently reported annual revenue of $0, a net loss of $43.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $0 $0 $0 $0 $0 Operating Profit $-170.0M $-171.0M $-181.0M $-65.0M $-46.0M Net Profit $-172.0M $-169.0M $-190.0M $-59.0M $-43.0M EPS $-63.02 $-50.60 $-42.09 $-11.73 $-2.85 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $287.0M $277.0M $191.0M $119.0M $122.0M Total Liabilities $61.0M $53.0M $45.0M $5.0M $43.0M Cash $202.0M $106.0M $90.0M $118.0M $98.0M Borrowings $30.0M $35.0M $27.0M $0 $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-106.0M $-142.0M $-124.0M $-68.0M $-38.0M Investing Cash Flow $186.0M $-80.0M $38.0M $95.0M $-20.0M Financing Cash Flow $0 $1.0M $0 $0 $155.0M Net Cash Flow $80.0M $-96.0M $-16.0M $27.0M $97.0M Free Cash Flow $-106.0M $-142.0M $-124.0M $-68.0M $-39.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -0.98 FCF Yield -64.48% Quick Ratio 12.14 Interest Coverage -46.00 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .